[Pharmacologic modification of cerebral activity: value of functional neuroimaging].
Identifieur interne : 001235 ( PubMed/Corpus ); précédent : 001234; suivant : 001236[Pharmacologic modification of cerebral activity: value of functional neuroimaging].
Auteurs : F. Chollet ; I. Loubinoux ; J. Pariente ; C. Carel ; J F Albucher ; O. Rascol ; B. Guiraud-ChaumeilSource :
- Revue neurologique [ 0035-3787 ] ; 2001.
English descriptors
- KwdEn :
- Animals, Brain (drug effects), Brain (physiopathology), Brain Mapping, Cerebral Infarction (physiopathology), Energy Metabolism (drug effects), Energy Metabolism (physiology), Humans, Magnetic Resonance Imaging, Neurotransmitter Agents (metabolism), Parkinson Disease (physiopathology), Receptors, Neurotransmitter (drug effects), Receptors, Neurotransmitter (physiology).
- MESH :
- chemical , drug effects : Receptors, Neurotransmitter.
- chemical , metabolism : Neurotransmitter Agents.
- drug effects : Brain, Energy Metabolism.
- physiology : Energy Metabolism, Receptors, Neurotransmitter.
- physiopathology : Brain, Cerebral Infarction, Parkinson Disease.
- Animals, Brain Mapping, Humans, Magnetic Resonance Imaging.
PubMed: 11677404
Links to Exploration step
pubmed:11677404Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Pharmacologic modification of cerebral activity: value of functional neuroimaging].</title><author><name sortKey="Chollet, F" sort="Chollet, F" uniqKey="Chollet F" first="F" last="Chollet">F. Chollet</name><affiliation><nlm:affiliation>INSERM U455 et Fédération de Neurologie, Hôpital Purpan, Place Baylac, 31059 Toulouse, France.</nlm:affiliation></affiliation></author><author><name sortKey="Loubinoux, I" sort="Loubinoux, I" uniqKey="Loubinoux I" first="I" last="Loubinoux">I. Loubinoux</name></author><author><name sortKey="Pariente, J" sort="Pariente, J" uniqKey="Pariente J" first="J" last="Pariente">J. Pariente</name></author><author><name sortKey="Carel, C" sort="Carel, C" uniqKey="Carel C" first="C" last="Carel">C. Carel</name></author><author><name sortKey="Albucher, J F" sort="Albucher, J F" uniqKey="Albucher J" first="J F" last="Albucher">J F Albucher</name></author><author><name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O" last="Rascol">O. Rascol</name></author><author><name sortKey="Guiraud Chaumeil, B" sort="Guiraud Chaumeil, B" uniqKey="Guiraud Chaumeil B" first="B" last="Guiraud-Chaumeil">B. Guiraud-Chaumeil</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2001">2001</date><idno type="RBID">pubmed:11677404</idno><idno type="pmid">11677404</idno><idno type="wicri:Area/PubMed/Corpus">001235</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001235</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Pharmacologic modification of cerebral activity: value of functional neuroimaging].</title><author><name sortKey="Chollet, F" sort="Chollet, F" uniqKey="Chollet F" first="F" last="Chollet">F. Chollet</name><affiliation><nlm:affiliation>INSERM U455 et Fédération de Neurologie, Hôpital Purpan, Place Baylac, 31059 Toulouse, France.</nlm:affiliation></affiliation></author><author><name sortKey="Loubinoux, I" sort="Loubinoux, I" uniqKey="Loubinoux I" first="I" last="Loubinoux">I. Loubinoux</name></author><author><name sortKey="Pariente, J" sort="Pariente, J" uniqKey="Pariente J" first="J" last="Pariente">J. Pariente</name></author><author><name sortKey="Carel, C" sort="Carel, C" uniqKey="Carel C" first="C" last="Carel">C. Carel</name></author><author><name sortKey="Albucher, J F" sort="Albucher, J F" uniqKey="Albucher J" first="J F" last="Albucher">J F Albucher</name></author><author><name sortKey="Rascol, O" sort="Rascol, O" uniqKey="Rascol O" first="O" last="Rascol">O. Rascol</name></author><author><name sortKey="Guiraud Chaumeil, B" sort="Guiraud Chaumeil, B" uniqKey="Guiraud Chaumeil B" first="B" last="Guiraud-Chaumeil">B. Guiraud-Chaumeil</name></author></analytic><series><title level="j">Revue neurologique</title><idno type="ISSN">0035-3787</idno><imprint><date when="2001" type="published">2001</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Brain (drug effects)</term><term>Brain (physiopathology)</term><term>Brain Mapping</term><term>Cerebral Infarction (physiopathology)</term><term>Energy Metabolism (drug effects)</term><term>Energy Metabolism (physiology)</term><term>Humans</term><term>Magnetic Resonance Imaging</term><term>Neurotransmitter Agents (metabolism)</term><term>Parkinson Disease (physiopathology)</term><term>Receptors, Neurotransmitter (drug effects)</term><term>Receptors, Neurotransmitter (physiology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="drug effects" xml:lang="en"><term>Receptors, Neurotransmitter</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Neurotransmitter Agents</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Brain</term><term>Energy Metabolism</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Energy Metabolism</term><term>Receptors, Neurotransmitter</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Brain</term><term>Cerebral Infarction</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Brain Mapping</term><term>Humans</term><term>Magnetic Resonance Imaging</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11677404</PMID><DateCreated><Year>2001</Year><Month>10</Month><Day>25</Day></DateCreated><DateCompleted><Year>2001</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2005</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0035-3787</ISSN><JournalIssue CitedMedium="Print"><Volume>157</Volume><Issue>8-9 Pt 1</Issue><PubDate><Year>2001</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Revue neurologique</Title><ISOAbbreviation>Rev. Neurol. (Paris)</ISOAbbreviation></Journal><ArticleTitle>[Pharmacologic modification of cerebral activity: value of functional neuroimaging].</ArticleTitle><Pagination><MedlinePgn>827-31</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chollet</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>INSERM U455 et Fédération de Neurologie, Hôpital Purpan, Place Baylac, 31059 Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loubinoux</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author ValidYN="Y"><LastName>Pariente</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Carel</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Albucher</LastName><ForeName>J F</ForeName><Initials>JF</Initials></Author><Author ValidYN="Y"><LastName>Rascol</LastName><ForeName>O</ForeName><Initials>O</Initials></Author><Author ValidYN="Y"><LastName>Guiraud-Chaumeil</LastName><ForeName>B</ForeName><Initials>B</Initials></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Modulation pharmacologique de l'activité cérébrale: apport de la neuroimagerie fonctionnelle.</VernacularTitle></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Rev Neurol (Paris)</MedlineTA><NlmUniqueID>2984779R</NlmUniqueID><ISSNLinking>0035-3787</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018377">Neurotransmitter Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017981">Receptors, Neurotransmitter</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001931" MajorTopicYN="N">Brain Mapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002544" MajorTopicYN="N">Cerebral Infarction</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004734" MajorTopicYN="N">Energy Metabolism</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018377" MajorTopicYN="N">Neurotransmitter Agents</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017981" MajorTopicYN="N">Receptors, Neurotransmitter</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><NumberOfReferences>45</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>10</Month><Day>26</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>1</Month><Day>5</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>10</Month><Day>26</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11677404</ArticleId><ArticleId IdType="pii">MDOI-RN-09-2001-157-8-9-0035-3787-101019-ART55</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001235 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001235 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:11677404
|texte= [Pharmacologic modification of cerebral activity: value of functional neuroimaging].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:11677404" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonFranceV1
| This area was generated with Dilib version V0.6.29. |  |